Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 31
2008 76
2009 114
2010 150
2011 235
2012 252
2013 324
2014 294
2015 261
2016 205
2017 206
2018 177
2019 187
2020 167
2021 105
2022 36
2023 40
2024 30

Search Results

2,414 results

Results by year

Filters applied: . Clear all
Page 1
Phosphodiesterase 5 inhibitors for pulmonary hypertension.
Barnes H, Brown Z, Burns A, Williams T. Barnes H, et al. Cochrane Database Syst Rev. 2019 Jan 31;1(1):CD012621. doi: 10.1002/14651858.CD012621.pub2. Cochrane Database Syst Rev. 2019. PMID: 30701543 Free PMC article.
Phosphodiesterase-5 inhibitors.
Cockrill BA, Waxman AB. Cockrill BA, et al. Handb Exp Pharmacol. 2013;218:229-55. doi: 10.1007/978-3-642-38664-0_10. Handb Exp Pharmacol. 2013. PMID: 24092343 Review.
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G; REPLACE investigators. Hoeper MM, et al. Lancet Respir Med. 2021 Jun;9(6):573-584. doi: 10.1016/S2213-2600(20)30532-4. Epub 2021 Mar 24. Lancet Respir Med. 2021. PMID: 33773120 Clinical Trial.
PDE-5 inhibitors: clinical points.
Doumas M, Lazaridis A, Katsiki N, Athyros V. Doumas M, et al. Curr Drug Targets. 2015;16(5):420-6. doi: 10.2174/1389450115666141111111301. Curr Drug Targets. 2015. PMID: 25392015 Review.
2,414 results